IDIBELL (Institut d'investigació biomédica de Bellvitge)http://www.idibell.cat/en-enNoticies d'IDIBELLIDIBELLFacial paralysis image processing software is awarded a grant by the Academy of Medical Sciences ]]>http://www.idibell.cat/modul/news/ca/1003/facial-paralysis-image-processing-software-is-awarded-a-grant-by-the-academy-of-medical-sciences2017-06-16The complete epigenomes of the most frequent tumors, unveiled ]]>http://www.idibell.cat/modul/news/ca/1001/the-complete-epigenomes-of-the-most-frequent-tumors-unveiled2017-06-06IDIBELL leads a new European Innovative Training Network

 The four-year project will finance 15 early stage researchers to explain the relationship between cancer, metabolism and the immune system

]]>
http://www.idibell.cat/modul/news/ca/1000/idibell-leads-a-new-european-innovative-training-network2017-05-30
Scientists identify new predisposing genes and microRNAS involved in hereditary cancer

Dr. Gabriel Capellá presents the hereditary cáncer-related projects of IDIBELL at the XI AECC Symposium 

]]>
http://www.idibell.cat/modul/news/ca/999/scientists-identify-new-predisposing-genes-and-micrornas-involved-in-hereditary-cancer2017-05-18
IDIBELL and CMRB launch a new Catalan Regenerative Medicine Program

The Center of Regenerative Medicine in Barcelona (CMR[B]) - currently located within the Barcelona Biomedical Research Park (PRBB) - and the Bellvitge Biomedical Research Institute (IDIBELL) have joined efforts to create the new Regenerative Medicine Program of Catalonia (P-CMR[C]).

]]>
http://www.idibell.cat/modul/news/ca/998/idibell-and-cmrb-launch-a-new-catalan-regenerative-medicine-program2017-05-08
Starvation causes atypical cell death

Stress signals sent by the endoplasmic reticulum could explain the mechanism of cell death in the tumor core and during ischemic episodes

]]>
http://www.idibell.cat/modul/news/ca/996/starvation-causes-atypical-cell-death2017-05-03
IDIBELL and ICO researchers take part in RCD Espanyol’s Heath Day ]]>http://www.idibell.cat/modul/news/ca/995/idibell-and-ico-researchers-take-part-in-rcd-espanyols-heath-day2017-04-28Chemoresistance in breast cancer is associated with the modulation of tumor cell populations ]]>http://www.idibell.cat/modul/news/ca/994/chemoresistance-in-breast-cancer-is-associated-with-the-modulation-of-tumor-cell-populations2017-04-28IDIBELL researchers look for new drugs against melanoma ]]>http://www.idibell.cat/modul/news/ca/992/idibell-researchers-look-for-new-drugs-against-melanoma2017-04-21Researchers describe a new pathophysiological process of megalencephalic leukoencephalopathy (MLC) in astrocytes ]]>http://www.idibell.cat/modul/news/ca/993/researchers-describe-a-new-pathophysiological-process-of-megalencephalic-leukoencephalopathy-mlc-in-astrocytes2017-04-24Bellvitge research receives 1 million euros in PERIS 2016-2020 funding ]]>http://www.idibell.cat/modul/news/ca/990/bellvitge-research-receives-1-million-euros-in-peris-2016-2020-funding2017-04-11First photoactive drug for pain treatments

Experts from the Institute of Neurosciences of the University of Barcelona, the Bellvitge Biomedical Research Institute (IDIBELL) and the Institute of Advanced Chemistry of Catalonia (IQAC) from CSIC, are designing the first light-operated drug to treat pain

]]>
http://www.idibell.cat/modul/news/ca/991/first-photoactive-drug-for-pain-treatments2017-04-11
An epigenetic lesion could be responsible for acute T-cell leukemia ]]>http://www.idibell.cat/modul/news/ca/989/an-epigenetic-lesion-could-be-responsible-for-acute-t-cell-leukemia2017-03-30The IT-LIVER European consortium unveils new TGF-beta functions in liver cancer ]]>http://www.idibell.cat/modul/news/ca/988/the-it-liver-european-consortium-unveils-new-tgf-beta-functions-in-liver-cancer2017-03-28The research in Neurofibromatosis receives again the support of the city of Manlleu ]]>http://www.idibell.cat/modul/news/ca/986/the-research-in-neurofibromatosis-receives-again-the-support-of-the-city-of-manlleu2017-03-22After the epigenome: the epitranscriptome ]]>http://www.idibell.cat/modul/news/ca/987/after-the-epigenome-the-epitranscriptome2017-03-22The second edition of IDIBELL PhD day highlights the potential of young researchers ]]>http://www.idibell.cat/modul/news/ca/984/the-second-edition-of-idibell-phd-day-highlights-the-potential-of-young-researchers2017-03-20ICS visits IDIBELL ]]>http://www.idibell.cat/modul/news/ca/985/ics-visits-idibell2017-03-20Cryopreserved orthoxenografts broaden the scope of single cell sequencing technologies ]]>http://www.idibell.cat/modul/news/ca/982/cryopreserved-orthoxenografts-broaden-the-scope-of-single-cell-sequencing-technologies2017-03-15First large-scale interactome map of the largest membrane receptors group in humans ]]>http://www.idibell.cat/modul/news/ca/983/first-large-scale-interactome-map-of-the-largest-membrane-receptors-group-in-humans2017-03-15IDIBELL joins #HeForShe on International Women's Day ]]>http://www.idibell.cat/modul/news/ca/981/idibell-joins-heforshe-on-international-womens-day2017-03-10Lifestyle choices condition colon and rectal cancer risk more than genetics

The first risk prediction model based on data from the Spanish population is issued

]]>
http://www.idibell.cat/modul/news/ca/980/lifestyle-choices-condition-colon-and-rectal-cancer-risk-more-than-genetics2017-03-06
Barcelona will hold the new edition of the Congress of the Spanish Society of Pharmacology ]]>http://www.idibell.cat/modul/news/ca/979/barcelona-will-hold-the-new-edition-of-the-congress-of-the-spanish-society-of-pharmacology2017-03-01Zumba fundraiser for Rett Syndrome ]]>http://www.idibell.cat/modul/news/ca/978/zumba-fundraiser-for-rett-syndrome2017-03-15La Regata Carla presenta una segunda edición dinámica y solidaria

El dinero recaudado se destinará a la investigación sobre el Síndrome de Rett

]]>
http://www.idibell.cat/modul/news/ca/977/la-regata-carla-presenta-una-segunda-edicion-dinamica-y-solidaria2017-02-24
IDIBELL and the Integral Health Consortium begin a research integration process ]]>http://www.idibell.cat/modul/news/ca/976/idibell-and-the-integral-health-consortium-begin-a-research-integration-process2017-02-22La AECC-Cataluña otorga dos becas a investigadores IDIBELL en su Noche Solidaria ]]>http://www.idibell.cat/modul/news/ca/975/la-aecc-cataluna-otorga-dos-becas-a-investigadores-idibell-en-su-noche-solidaria2017-02-21Adenoviruses and the immune system join forces against cancer ]]>http://www.idibell.cat/modul/news/ca/974/adenoviruses-and-the-immune-system-join-forces-against-cancer2017-02-16Women and science: past, present and future ]]>http://www.idibell.cat/modul/news/ca/973/women-and-science-past-present-and-future2017-02-17Conference on health technologies within the Mobile World Congress framework ]]>http://www.idibell.cat/modul/news/ca/972/conference-on-health-technologies-within-the-mobile-world-congress-framework2017-02-10A Nature study reinforces the contribution of S6K1 kinase in obesity and aging

EPRS phosphorylation mediates S6K1-dependent metabolic responses related to obesity and aging

]]>
http://www.idibell.cat/modul/news/ca/971/a-nature-study-reinforces-the-contribution-of-s6k1-kinase-in-obesity-and-aging2017-02-08
100.000 pebrots contra el càncer ]]>http://www.idibell.cat/modul/news/ca/970/100000-pebrots-contra-el-cancer2017-02-03Bastos Medical, committed to IDIBELL’s ovarian cancer research ]]>http://www.idibell.cat/modul/news/ca/969/bastos-medical-committed-to-idibells-ovarian-cancer-research2017-02-01European experts highlight the potential of xenografts in personalized oncology ]]>http://www.idibell.cat/modul/news/ca/968/european-experts-highlight-the-potential-of-xenografts-in-personalized-oncology2017-01-30A new strategy to improve genetic diagnosis for families with hereditary cancer ]]>http://www.idibell.cat/modul/news/ca/967/a-new-strategy-to-improve-genetic-diagnosis-for-families-with-hereditary-cancer2017-01-27El Hotel Barcelona Princess entrega 16.000€ a la investigación de las enfermedades raras ]]>http://www.idibell.cat/modul/news/ca/966/el-hotel-barcelona-princess-entrega-16000-a-la-investigacion-de-las-enfermedades-raras2017-01-26Inactivation of the B2M gene is recurrent in lung cancer and may condition the response to immunotherapy ]]>http://www.idibell.cat/modul/news/ca/965/inactivation-of-the-b2m-gene-is-recurrent-in-lung-cancer-and-may-condition-the-response-to-immunotherapy2017-01-16SB Hotels Tarragona Marathon wants to tear down the wall of childhood cancer

In its 7th edition, the sports test will collect voluntary donations for the investigation of children's sarcoma that is carried out in the IDIBELL

]]>
http://www.idibell.cat/modul/news/ca/964/sb-hotels-tarragona-marathon-wants-to-tear-down-the-wall-of-childhood-cancer2017-01-11
A bronchial GPS based on digital imaging for the early detection of lung cancer ]]>http://www.idibell.cat/modul/news/ca/963/a-bronchial-gps-based-on-digital-imaging-for-the-early-detection-of-lung-cancer2017-01-17Gabriel Capellá, director of IDIBELL ]]>http://www.idibell.cat/modul/news/ca/962/gabriel-capella-director-of-idibell2016-12-30Researchers describe the causes of resistance of tumor cells to therapy with mTOR inhibitors ]]>http://www.idibell.cat/modul/news/ca/961/researchers-describe-the-causes-of-resistance-of-tumor-cells-to-therapy-with-mtor-inhibitors2016-12-21Researchers identify new suppressor effects of the NOX4 protein in liver cancer ]]>http://www.idibell.cat/modul/news/ca/960/researchers-identify-new-suppressor-effects-of-the-nox4-protein-in-liver-cancer2016-12-19L’Hospitalet Christmas Concerts raise funds for IDIBELL

The City Council and the research center join forces to raise funds against intellectual disability

]]>
http://www.idibell.cat/modul/news/ca/959/lhospitalet-christmas-concerts-raise-funds-for-idibell2016-12-19
CaixaImpulse funds an IDIBELL project on hospital-acquired infections ]]>http://www.idibell.cat/modul/news/ca/958/caixaimpulse-funds-an-idibell-project-on-hospital-acquired-infections2016-12-13Success of the 1st Charity Night for Research on Cystic Fibrosis ]]>http://www.idibell.cat/modul/news/ca/957/success-of-the-1st-charity-night-for-research-on-cystic-fibrosis2016-12-07IDIBELL, a ''Company with Value'' ]]>http://www.idibell.cat/modul/news/ca/956/idibell-a-company-with-value2016-12-01The first analysis of Ewing's sarcoma methyloma opens doors to new treatments ]]>http://www.idibell.cat/modul/news/ca/955/the-first-analysis-of-ewings-sarcoma-methyloma-opens-doors-to-new-treatments2016-11-30The EPICUP test, amongst the “Best ideas” 2016 ]]>http://www.idibell.cat/modul/news/ca/954/the-epicup-test-amongst-the-best-ideas-20162016-11-30New antiretroviral drugs decrease chances of HIV sexual transmission

A triple regimen based on an integrase inhibitor decreases viral load in semen very quickly, reducing transmission risk

]]>
http://www.idibell.cat/modul/news/ca/953/new-antiretroviral-drugs-decrease-chances-of-hiv-sexual-transmission2016-11-17
How does the brain of people who do not like music work? ]]>http://www.idibell.cat/modul/news/ca/952/how-does-the-brain-of-people-who-do-not-like-music-work2016-11-1811.850 euros for the investigation of children's sarcoma in IDIBELL

The "Viladecans Against Cancer" Association delivers the funds raised during the second edition of its traditional Paella

]]>
http://www.idibell.cat/modul/news/ca/950/11850-euros-for-the-investigation-of-childrens-sarcoma-in-idibell2016-11-14
IDIBELL joins the ADVANCECAT project to promote advanced therapies in Catalonia ]]>http://www.idibell.cat/modul/news/ca/949/idibell-joins-the-advancecat-project-to-promote-advanced-therapies-in-catalonia2016-11-11Good practices in the management of European FEDER/FSE research grants ]]>http://www.idibell.cat/modul/news/ca/948/good-practices-in-the-management-of-european-federfse-research-grants2016-11-10IDIBELL’s innovation strategy in Medesalud 2016 ]]>http://www.idibell.cat/modul/news/ca/947/idibells-innovation-strategy-in-medesalud-20162016-11-093 IDIBELL diabetes and obesity research teams receive funding from La Marató de TV3 Foundation

The projects led by researchers Antonio Agudo, Genevieve Buckland and Sara Kozma are among the 34 projects selected to find new ways of prevention, diagnosis and treatment for the two most frequent metabolic diseases in Catalonia

]]>
http://www.idibell.cat/modul/news/ca/945/3-idibell-diabetes-and-obesity-research-teams-receive-funding-from-la-marato-de-tv3-foundation2016-11-04
Scientists discover a cause of multiple resistance to cancer chemotherapy ]]>http://www.idibell.cat/modul/news/ca/946/scientists-discover-a-cause-of-multiple-resistance-to-cancer-chemotherapy2016-11-04IDIBELL and the Llobregat Business Forum, together in the 1st Research charity night

The benefits of the Night will fund a project against cystic fibrosis

]]>
http://www.idibell.cat/modul/news/ca/944/idibell-and-the-llobregat-business-forum-together-in-the-1st-research-charity-night2016-11-16
Researcher Marta Díez-Ferrer is awarded for a study that improves 3D rendering of the tracheobronchial tree ]]>http://www.idibell.cat/modul/news/ca/943/researcher-marta-diez-ferrer-is-awarded-for-a-study-that-improves-3d-rendering-of-the-tracheobronchial-tree2016-11-02Cancer causing human papillomavirus lineage originate by sexual transmission from Neanderthals ]]>http://www.idibell.cat/modul/news/ca/942/cancer-causing-human-papillomavirus-lineage-originate-by-sexual-transmission-from-neanderthals2016-10-27Manel Esteller, Josep Baselga and Joan Massagué receive the XXVIII Catalonia International Prize from President Puigdemont ]]>http://www.idibell.cat/modul/news/ca/941/manel-esteller-josep-baselga-and-joan-massague-receive-the-xxviii-catalonia-international-prize-from-president-puigdemont2016-10-26Grupo Témporing supports IDIBELL's research on ELA ]]>http://www.idibell.cat/modul/news/ca/939/grupo-temporing-supports-idibells-research-on-ela2016-10-19Identified a key protein in the generation of B lymphocytes ]]>http://www.idibell.cat/modul/news/ca/938/identified-a-key-protein-in-the-generation-of-b-lymphocytes2016-10-14The XII Marató del Mediterrani raises 500 euros for autoimmune diseases research ]]>http://www.idibell.cat/modul/news/ca/937/the-xii-marato-del-mediterrani-raises-500-euros-for-autoimmune-diseases-research2016-10-13Researchers identify a key molecule in psoriasis development ]]>http://www.idibell.cat/modul/news/ca/936/researchers-identify-a-key-molecule-in-psoriasis-development2016-10-04The XII Mediterranean Marathon will run to overcome autoimmune diseases ]]>http://www.idibell.cat/modul/news/ca/935/the-xii-mediterranean-marathon-will-run-to-overcome-autoimmune-diseases2016-10-10IDIBELL presents its technology portfolio in Biospain 2016

From today until next Friday, the business development & innovation area of IDIBELL will participate in the eighth edition of Biospain 2016, the most important biotech event in southern Europe

]]>
http://www.idibell.cat/modul/news/ca/934/idibell-presents-its-technology-portfolio-in-biospain-20162016-09-29
When learning is fun – scientists prove how the brain simulates external rewards to boost memory formation ]]>http://www.idibell.cat/modul/news/ca/933/when-learning-is-fun-scientists-prove-how-the-brain-simulates-external-rewards-to-boost-memory-formation2016-09-26ONCE and IDIBELL working together in a Project on Retinitis Pigmentosa

The research deals with functional studies of genes linked to a type of inherited blindness in order to identify potential therapeutic targets

]]>
http://www.idibell.cat/modul/news/ca/931/once-and-idibell-working-together-in-a-project-on-retinitis-pigmentosa2016-09-26
Scientists find mutations associated with unusual forms of Rett syndrome ]]>http://www.idibell.cat/modul/news/ca/932/scientists-find-mutations-associated-with-unusual-forms-of-rett-syndrome2016-09-26Magda Martí, new managing director of IDIBELL ]]>http://www.idibell.cat/modul/news/ca/928/magda-marti-new-managing-director-of-idibell2016-09-20Scientists prove the effectiveness of a new combination of drugs in a type of incurable lung cancer

The study follows a promising lead for a disease for which there is no available treatment at the moment

]]>
http://www.idibell.cat/modul/news/ca/929/scientists-prove-the-effectiveness-of-a-new-combination-of-drugs-in-a-type-of-incurable-lung-cancer2016-09-21
INPhINIT, the new ”la Caixa” Doctoral Fellowship Programme ]]>http://www.idibell.cat/modul/news/ca/926/inphinit-the-new-la-caixa-doctoral-fellowship-programme2016-09-14Therapeutic RANK inhibition reduces breast cancer recurrence ]]>http://www.idibell.cat/modul/news/ca/923/therapeutic-rank-inhibition-reduces-breast-cancer-recurrence2016-09-13Dr. Conxi Lázaro is awarded the Theodor Schwann Prize for his research in the field of neurofibromatosis ]]>http://www.idibell.cat/modul/news/ca/925/dr-conxi-lazaro-is-awarded-the-theodor-schwann-prize-for-his-research-in-the-field-of-neurofibromatosis2016-09-13Catalonia's Parliament awards its medal of honor to IDIBELL's researcher Manel Esteller ]]>http://www.idibell.cat/modul/news/ca/924/catalonias-parliament-awards-its-medal-of-honor-to-idibells-researcher-manel-esteller2016-09-11Tumor microenvironment acts as a mechanism of resistance to chemotherapy in colorectal cancer

A new study highlights the importance of the tumor environment as a source of resistance to treatment in colorectal cancer, the fourth most common cancer and the leading cause of cancer death worldwide.

]]>
http://www.idibell.cat/modul/news/ca/921/tumor-microenvironment-acts-as-a-mechanism-of-resistance-to-chemotherapy-in-colorectal-cancer2016-09-02
The European project ANTI-SUPERBUGS PCP kicks off to join the fight against superbugs ]]>http://www.idibell.cat/modul/news/ca/922/the-european-project-anti-superbugs-pcp-kicks-off-to-join-the-fight-against-superbugs2016-09-05A new animal model to understand metastasis in sarcomas ]]>http://www.idibell.cat/modul/news/ca/920/a-new-animal-model-to-understand-metastasis-in-sarcomas2016-08-25The first epigenetic test to identify tumors of unknown primary

The EPICUP® test is a new tool that helps identify up to 87% of cases of cancer of unknown origin (CUP)

]]>
http://www.idibell.cat/modul/news/ca/919/the-first-epigenetic-test-to-identify-tumors-of-unknown-primary2016-08-29
Not all tumor cells are equal

Scientists find that colorectal tumors present epigenetic heterogeneity relates to the clinical course of the disease.

]]>
http://www.idibell.cat/modul/news/ca/918/not-all-tumor-cells-are-equal2016-08-18
Alvaro Aytes receives one of 60 grants from the BBVA Foundation for researchers and creators

With this initiative, the BBVA Foundation promotes individual effort for the collective benefit of professionals in an intermediate stage of his career and who have demonstrated high productivity and innovativeness

]]>
http://www.idibell.cat/modul/news/ca/917/alvaro-aytes-receives-one-of-60-grants-from-the-bbva-foundation-for-researchers-and-creators2016-08-03
IDIBELL is rewarded by MC Mutual for its prevention and occupational health actions ]]>http://www.idibell.cat/modul/news/ca/915/idibell-is-rewarded-by-mc-mutual-for-its-prevention-and-occupational-health-actions2016-07-26Manel Esteller, Joan Massagué and Josep Baselga are awarded the Catalunya International Prize ]]>http://www.idibell.cat/modul/news/ca/916/manel-esteller-joan-massague-and-josep-baselga-are-awarded-the-catalunya-international-prize2016-07-28The AutonoMe project receives 39,850 euros to improve the quality of life of people with disabilities

The Ave Maria Foundation, in collaboration with IDIBELL, has been selected in the call for "Promotion of Autonomy and Care for Aging, Disability and Dependence 2016" of "la Caixa"

]]>
http://www.idibell.cat/modul/news/ca/914/the-autonome-project-receives-39850-euros-to-improve-the-quality-of-life-of-people-with-disabilities2016-07-22
The Catalan Parliament agrees to award researcher Manel Esteller its gold Medal of Honor ]]>http://www.idibell.cat/modul/news/ca/912/the-catalan-parliament-agrees-to-award-researcher-manel-esteller-its-gold-medal-of-honor2016-07-20New IDSA/ATS guidelines say less antibiotics for hospital-acquired, ventilator-associated pneumonia

Dr Jordi Carratalà, IDIBELL researcher, is a member of the international panel that created these new guidelines published by the Infectious Diseases Society of America and the American Thoracic Society.

]]>
http://www.idibell.cat/modul/news/ca/913/new-idsaats-guidelines-say-less-antibiotics-for-hospital-acquired-ventilator-associated-pneumonia2016-07-25
The Giró company, patron of IDIBELL ]]>http://www.idibell.cat/modul/news/ca/910/the-giro-company-patron-of-idibell2016-07-28Gabriel Capellá temporarily assumes the direction of IDIBELL

Jaume Reventós is appointed new coordinator of strategy and institutional relations of the General Directorate for Research and Innovation in Health

]]>
http://www.idibell.cat/modul/news/ca/911/gabriel-capella-temporarily-assumes-the-direction-of-idibell2016-07-19
Tractivus, ACCIÓ Investment Forum Award finalist ]]>http://www.idibell.cat/modul/news/ca/909/tractivus-acci-investment-forum-award-finalist2016-07-21Mireia Martin-Satué is awarded a Merck Research Grant 2016 to carry out a project on fertility ]]>http://www.idibell.cat/modul/news/ca/908/mireia-martin-satue-is-awarded-a-merck-research-grant-2016-to-carry-out-a-project-on-fertility2016-07-15IDIBELL and the ECOM Foundation sign a collaboration agreement to promote awareness and inclusion of handicapped staff ]]>http://www.idibell.cat/modul/news/ca/907/idibell-and-the-ecom-foundation-sign-a-collaboration-agreement-to-promote-awareness-and-inclusion-of-handicapped-staff2016-07-15IDIBELL scientists identify an epigenetic mechanism involved in the development of autoinflammatory diseases ]]>http://www.idibell.cat/modul/news/ca/905/idibell-scientists-identify-an-epigenetic-mechanism-involved-in-the-development-of-autoinflammatory-diseases2016-07-11A ‘Big Data’ Approach to Developing Cancer Drugs

Scientists develop a catalog of 1000 tumors with their alterations and drug sensitivities

]]>
http://www.idibell.cat/modul/news/ca/906/a-big-data-approach-to-developing-cancer-drugs2016-07-08
Researcher Manel Esteller is awarded a 2016 Proof of Concept top-funding European grant ]]>http://www.idibell.cat/modul/news/ca/903/researcher-manel-esteller-is-awarded-a-2016-proof-of-concept-top-funding-european-grant2016-07-08IDIBELL will test a new technology designed to improve high-precision personalized medicine in hereditary cancer

Five leading research institutions (IDIBELL, Hospital del Mar, Irsicaixa, VHIO and VHIR) create the 'Next-Next Generation Sequencing' Platform, together with Roche Diagnostics, to develop diagnostic applications of cancer and infectious diseases

]]>
http://www.idibell.cat/modul/news/ca/904/idibell-will-test-a-new-technology-designed-to-improve-high-precision-personalized-medicine-in-hereditary-cancer2016-07-07
IDIBELL, supporting rare disease research

IDIBELL has endorsed the document of recommendations for finding solutions in the field of rare diseases by AELMHU and FEDER, and the Rett Syndrome awareness campaign "El Retto"

]]>
http://www.idibell.cat/modul/news/ca/902/idibell-supporting-rare-disease-research2017-02-28
A new computational method will help track the progression of colon cancer ]]>http://www.idibell.cat/modul/news/ca/901/a-new-computational-method-will-help-track-the-progression-of-colon-cancer2016-06-27Epigenetic testing has the same quality as genetic testing

This international validation of epigenetic tests will fuel its clinical implementation

]]>
http://www.idibell.cat/modul/news/ca/900/epigenetic-testing-has-the-same-quality-as-genetic-testing2016-08-01
IDIBELL and IQS license a technology to enhance a new tracheal stent the spin-off Tractivus

Tractivus, a spin-off from IQS and IDIBELL, aims to revolutionize current stents and provide a solution to an unmet clinical need in order to improve the quality of life of patients and avoid extra costs for the health system

]]>
http://www.idibell.cat/modul/news/ca/899/idibell-and-iqs-license-a-technology-to-enhance-a-new-tracheal-stent-the-spin-off-tractivus2016-06-22
The PI3K protein: a potential new therapeutic target in pancreatic neuroendocrine tumors

Researchers from the Institute of Biomedical Investigation of Bellvitge (IDIBELL) have demonstrated that selective inactivation of the p110α PI3K isoform is sufficient to block tumor progression and metastasis in a mice model of PanNETs.

]]>
http://www.idibell.cat/modul/news/ca/898/the-pi3k-protein-a-potential-new-therapeutic-target-in-pancreatic-neuroendocrine-tumors2016-06-16